L. Hvolris

The Peripheral Perfusion Index tracks systemic haemodynamics during general anaesthesia

N. B. Foss, M. Agerskov, J. Højlund, 2019, Journal of Clinical Monitoring and Computing.

Changes in Gastrointestinal Hormone Responses, Insulin Sensitivity, and Beta-Cell Function Within 2 Weeks After Gastric Bypass in Non-diabetic Subjects

J. Holst, J. Rehfeld, B. Wulff, 2012, Obesity Surgery.

Carotid intima-media thickness is reduced 12 months after gastric bypass surgery in obese patients with type 2 diabetes or impaired glucose tolerance.

A. Vaag, L. Tarnow, T. Almdal, 2014, Journal of diabetes and its complications.

Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report.

J. Holst, S. Madsbad, K. N. Bojsen-Møller, 2013, Obesity research & clinical practice.

Increased glucose‐stimulated FGF21 response to oral glucose in obese nondiabetic subjects after Roux‐en‐Y gastric bypass

J. Holst, B. Wulff, S. Madsbad, 2017, Clinical endocrinology.

Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.

J. Holst, B. Wulff, S. Madsbad, 2012, American journal of physiology. Endocrinology and metabolism.

Postprandial Diabetic Glucose Tolerance Is Normalized by Gastric Bypass Feeding as Opposed to Gastric Feeding and Is Associated With Exaggerated GLP-1 Secretion

J. Holst, S. Madsbad, L. Hvolris, 2009, Diabetes Care.

Gastric bypass surgery reveals independency of obesity and diabetes melitus type 2

V. Kristiansen, S. Madsbad, M. Fenger, 2016, BMC Endocrine Disorders.

Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report.

J. Holst, S. Madsbad, K. N. Bojsen-Møller, 2013, Obesity research & clinical practice.